-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, COuzAyyZf9wDHvBtQ2MMNXk1Rj24rtvAdW5jzRHlbNLMrYbRuyY/JiUoc3MhAMhe 0PuRMFfa5hdmS/tE1+7bow== 0000906337-96-000005.txt : 19960719 0000906337-96-000005.hdr.sgml : 19960719 ACCESSION NUMBER: 0000906337-96-000005 CONFORMED SUBMISSION TYPE: 10-C PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19960708 FILED AS OF DATE: 19960718 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROXYMED INC /FT LAUDERDALE/ CENTRAL INDEX KEY: 0000906337 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 650202059 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-C SEC ACT: 1934 Act SEC FILE NUMBER: 000-22052 FILM NUMBER: 96596324 BUSINESS ADDRESS: STREET 1: 2501 DAVIE RD STE 230 CITY: FT LAUDERDALE STATE: FL ZIP: 33317-7424 BUSINESS PHONE: 3054731001 FORMER COMPANY: FORMER CONFORMED NAME: HMO PHARMACY INC DATE OF NAME CHANGE: 19930601 10-C 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-C REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ INTERDEALER QUOTATION SYSTEM Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and Rule 13a-17 or 15d-17 thereunder PROXYMED, INC. (Exact name of issuer as specified in its charter) 2501 DAVIE ROAD, SUITE 230, FT. LAUDERDALE, FLORIDA 33317 (Address of principal executive offices) Issuer's telephone number, including area code (954) 473-1001 I. CHANGE IN NUMBER OF SHARES OUTSTANDING Indicate any change (increase or decrease) of 5% or more in the number of shares outstanding: 1. Title of security: Common Stock, $.001 par value 2. Number of shares outstanding before the change:5,854,227 3. Number of shares outstanding after the change: 8,781,341* 4. Effective date of change July 8, 1996 5. Method of change: Specify method (such as merger, acquisition, exchange, distribution, stock split, reverse split, acquisition of stock for treasury, etc.): 3 for 2 stock split Give brief description of transaction: The company effected a 3 for 2 stock split whereby on July 8, 1996 shareholders received one share for every 2 shares owned. Cash was paid in lieu of fractional shares. *In addition, the company recently exercised its rights to convert its outstanding Series A Preferred Stock to common stock and redeem certain of its outstanding warrants (subject to prior exercise). Effective August 2, 1996, there will be approxi- mately 691,000 additional shares outstanding assuming all warrants are exercised. II. CHANGE IN NAME OF ISSUER 1. Name prior to change: 2. Name after change: 3. Effective date of charter amendment changing name: 4. Date of shareholder approval of change, if required: PROXYMED, INC. Date:July 18, 1996 By: /s/Bennett Marks Bennett Marks, E.V.P.-Finance -----END PRIVACY-ENHANCED MESSAGE-----